Strategic Analysis on World Congestive Heart Failure (CHF) Treatment Devices Market 2022

1
World Congestive Heart Failure (CHF) Treatment
Devices Market - Opportunities and Forecasts,
2015 - 2022
Published Date 01 May, 2016 No of Pages
135 Single User Price 4740
World CHF Treatment Devices Market is estimated
to reach 14,823.3 million by 2022
Click Here To Check Complete Report
2

• Congestive heart failure (CHF) is a physiological
  condition that has an adverse impact on the
  pumping efficiency of the cardiac muscles.
• It characterizes the accumulation of fluid around
  the heart leading to inefficient pumping.
• The onset of CHF is marked by the failure of the
  ventricles to pump sufficient volume of blood to
  the body organs.
• This eventually leads to deposition of fluid in
  the lungs, abdomen, liver, and lower body.
• CHF is treated by a number of devices that
  maintain heart rhythm, such as pacemakers,
  cardiac resynchronization therapy (CRT),
  implantable cardioverter defibrillators (ICDs),
  and ventricular assist devices (VADs).
• The world CHF treatment devices market was
  evaluated at 10,127.2 million in 2015, and is
  estimated to reach 14,823.3 million by 2022,
  with a CAGR of 5.5 over the forecast period.
• This is primarily attributed to the constantly
  changing lifestyle habits (such as unhealthy
  dietary habits, excessive alcohol consumption,
  smoking, obesity, and lack of physical activity)
  which make individuals more susceptible to
  arrhythmia and heart failure.

3

• In addition, a number of factors such as the
  large number of technological advancements in CHF
  treatment devices, increased adoption rate of
  these devices, and rising emphasis on early
  intervention and primary prevention of
  heart-related disorders are responsible for
  driving the market.
• Conversely, stringent government regulations for
  the approval of CHF treatment devices, high cost
  of, and high preference to drugs for CHF
  treatment are some of the factors restraining the
  market growth.
• The report segments the world CHF treatment
  devices market based on product type, namely,
  pacemakers, cardiac resynchronization therapy
  (CRT) devices, implantable cardioverter
  defibrillators (ICDs), and ventricular assist
  devices (VADs).
• Pacemaker is further segmented into dual-chamber
  pacemakers and single-chamber pacemakers.
• CRT devices is segmented into two major types,
  namely, CRT-P and CRT-D. ICDs is further
  segmented into transvenous implantable
  cardioverter defibrillator (T-ICDs) and
  subcutaneous implantable cardioverter
  defibrillator (S-ICDs).
• VADs is also segmented into left ventricular
  assist device (LVAD), right ventricular assist
  device (RVAD), and biventricular assist device
  (BIVAD).

4

• ICDs was the highest revenue-generating segment
  in 2015, owing to the stressful hyperactive
  lifestyle, unhealthy food habits, and growing
  number of aging population.
• Based on geography, the market is divided into
  North America, Europe, Asia-Pacific, and LAMEA
  regions.
• The key players in this market adopted product
  development and product launch as their key
  strategies to keep pace with the changing demands
  of consumers.
• Furthermore, companies launched cost-effective
  and technologically efficient products to
  strengthen their market position.
• The report provides a comprehensive analysis of
  the key players operating in the world CHF
  treatment devices market, such as Abiomed, Inc.,
  Berlin Heart GmbH, Biotronik SE Co. KG, Boston
  Scientific Corporation, HeartWare International,
  Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic
  plc, ReliantHeart Inc., and St. Jude Medical,
  Inc.
• Key Benefits The study provides an in-depth
  analysis of the world CHF treatment devices
  market with current trends and future estimations
  to elucidate the imminent investment pockets in
  the market.

Make an Inquiry Before Buying
5

• The report provides a comprehensive analysis of
  the key players operating in the world CHF
  treatment devices market, such as Abiomed, Inc.,
  Berlin Heart GmbH, Biotronik SE Co. KG, Boston
  Scientific Corporation, HeartWare International,
  Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic
  plc, ReliantHeart Inc., and St. Jude Medical,
  Inc.
• Key Benefits The study provides an in-depth
  analysis of the world CHF treatment devices
  market with current trends and future estimations
  to elucidate the imminent investment pockets in
  the market.
• The report provides a quantitative analysis from
  2015 to 2022 that would enable the stakeholders
  to capitalize on prevailing market opportunities.
  
• Extensive analysis of the world CHF treatment
  devices market, by product, helps in
  understanding the various types of devices used
  for the treatment of CHF and other related
  cardiac conditions.
• Competitive intelligence highlights the business
  practices followed by leading market players
  across various geographic regions.

Download Sample Brochure
6

• SWOT analysis enables to study the internal
  environment of the leading companies for strategy
  formulation.
• CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES
  MARKET KEY SEGMENTS Congestive Heart Failure
  (CHF) Treatment Devices Market,
• By Product Pacemakers,
• By Type Implantable Pacemakers External
  Pacemakers Cardiac Resynchronization Therapy
  (CRT), By Type Cardiac Resynchronization
  Therapy-Pacemakers (CRT-P)Cardiac
  Resynchronization Therapy-Defibrillators
  (CRT-D)Implantable Cardioverter Defibrillators
  (ICDs),
• By TypeTransvenous Implantable Cardioverter
  Defibrillator (T-ICDs)Subcutaneous Implantable
  Cardioverter Defibrillator (S-ICDs)Ventricular
  Assist Devices (VADs),
• By Type Left Ventricular Assist Device
  (LVAD)Right Ventricular Assist Device
  (RVAD)Biventricular Assist Device (BIVAD)
• By Geography North AmericaU.S.CanadaMexicoEuropeGe
  rmanyU.K.FranceRest of EuropeAsia-PacificJapanChin
  aIndiaRest of Asia-PacificLAMEALatin
  AmericaMiddle EastAfrica

7
World Congestive Heart Failure (CHF) Treatment
Devices Market - Opportunities and Forecasts,
2015 - 2022
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the World Congestive Heart Failure (CHF)
Treatment Devices Market and future opportunities
are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.
com www.marketintelreports.com
Click here to order a copy of World Congestive
Heart Failure (CHF) Treatment Devices Market
Report